Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

10 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
VEGF and the quest for tumour angiogenesis factors.
Ferrara N. Ferrara N. Nat Rev Cancer. 2002 Oct;2(10):795-803. doi: 10.1038/nrc909. Nat Rev Cancer. 2002. PMID: 12360282 Review.
Diabetic patients and retinal proliferation: an evaluation of the role of vascular endothelial growth factor (VEGF).
Nicoletti VG, Nicoletti R, Ferrara N, Meli G, Reibaldi M, Reibaldi A. Nicoletti VG, et al. Among authors: ferrara n. Exp Clin Endocrinol Diabetes. 2003 Jun;111(4):209-14. doi: 10.1055/s-2003-40465. Exp Clin Endocrinol Diabetes. 2003. PMID: 12845559
The role of vascular endothelial growth factor in angiogenesis.
Ferrara N, Gerber HP. Ferrara N, et al. Acta Haematol. 2001;106(4):148-56. doi: 10.1159/000046610. Acta Haematol. 2001. PMID: 11815711 Review.
VEGF regulates cell behavior during vasculogenesis.
Drake CJ, LaRue A, Ferrara N, Little CD. Drake CJ, et al. Among authors: ferrara n. Dev Biol. 2000 Aug 15;224(2):178-88. doi: 10.1006/dbio.2000.9744. Dev Biol. 2000. PMID: 10926758
A repressor sequence in the juxtamembrane domain of Flt-1 (VEGFR-1) constitutively inhibits vascular endothelial growth factor-dependent phosphatidylinositol 3'-kinase activation and endothelial cell migration.
Gille H, Kowalski J, Yu L, Chen H, Pisabarro MT, Davis-Smyth T, Ferrara N. Gille H, et al. Among authors: ferrara n. EMBO J. 2000 Aug 1;19(15):4064-73. doi: 10.1093/emboj/19.15.4064. EMBO J. 2000. PMID: 10921887 Free PMC article.
The second immunoglobulin-like domain of the VEGF tyrosine kinase receptor Flt-1 determines ligand binding and may initiate a signal transduction cascade.
Davis-Smyth T, Chen H, Park J, Presta LG, Ferrara N. Davis-Smyth T, et al. Among authors: ferrara n. EMBO J. 1996 Sep 16;15(18):4919-27. EMBO J. 1996. PMID: 8890165 Free PMC article.
Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene.
Ferrara N, Carver-Moore K, Chen H, Dowd M, Lu L, O'Shea KS, Powell-Braxton L, Hillan KJ, Moore MW. Ferrara N, et al. Nature. 1996 Apr 4;380(6573):439-42. doi: 10.1038/380439a0. Nature. 1996. PMID: 8602242
Leukemia inhibitory factor expression in human carotid plaques: possible mechanism for inhibition of large vessel endothelial regrowth.
Gillett NA, Lowe D, Lu L, Chan C, Ferrara N. Gillett NA, et al. Among authors: ferrara n. Growth Factors. 1993;9(4):301-5. doi: 10.3109/08977199308991590. Growth Factors. 1993. PMID: 8148158
Placenta growth factor. Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-1/KDR.
Park JE, Chen HH, Winer J, Houck KA, Ferrara N. Park JE, et al. Among authors: ferrara n. J Biol Chem. 1994 Oct 14;269(41):25646-54. J Biol Chem. 1994. PMID: 7929268
VEGF: an update on biological and therapeutic aspects.
Ferrara N. Ferrara N. Curr Opin Biotechnol. 2000 Dec;11(6):617-24. doi: 10.1016/s0958-1669(00)00153-1. Curr Opin Biotechnol. 2000. PMID: 11102799 Review.